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Signaling pathways that are activated upon interaction of glial cell-line 
derived neurotrophic factor (Gdnf), its 
coreceptor Gfrα1 and receptor tyrosine 
kinase Ret are critical for kidney develop-
ment and ureter maturation. Outside the 
kidney, this pathway is implicated in a 
number of congenital diseases including 
Hirschsprung disease (intestinal agan-
glionosis, HSCR) and hereditary cancer 
syndromes (MEN 2). Total lack of Gdnf, 
Gfrα1 or Ret in mice results in perinatal 
lethality due to bilateral renal agenesis 
or aplasia. In humans, RET mutations 
have been identified in a spectrum of 
congenital malformations involving the 
RET axis including isolated HSCR, iso-
lated congenital anomalies of kidney or 
urinary tract (CAKUT) or CAKUT and 
HSCR together. The molecular basis for 
these pleiotropic effects of RET has just 
begun to be unraveled. In an effort to 
delineate the pathogenetic mechanisms 
that underlie these congenital malforma-
tions, we and others have characterized 
Ret’s role in early kidney and urinary 
system development. Here we present a 
brief overview of the many faces of Ret 
dysfunction in kidney with particular 
emphasis on Ret’s signaling specificity 
and intergenic interactions that confer 
normal urinary system development.
Clinical Aspects of Congenital 
Urinary Tract Anomalies
Congenital anomalies of kidney or lower 
urinary tract (CAKUT) are common 
anomalies (1 in 250 live births) and the 
most common cause of renal failure in 
children.1 These include renal hypoplasia/
dysplasia, agenesis, hydronephrosis, 
megaureter/hydroureter, duplicated col-
lecting system, abnormal valves and dis-
tal obstruction. The abnormalities can 
occur in isolation, or as a complex, or as 
a part of other syndromes involving mul-
tiple organ systems. In some cases they are 
incompatible with life and even after sur-
gical correction, many patients progress to 
renal failure or have associated comorbidi-
ties that include skeletal, cardiovascular 
and hematopoeitic systems. Thus, there 
is considerable interest in understand-
ing molecular genetics of CAKUT and 
related diseases. In many respects, rodent 
kidney development is similar to human 
kidney development. For example, kid-
ney development in both occurs in an 
anterior to posterior direction in three 
stages, pronephros, mesonephros and 
metanephros (see below). Further, several 
genes have been identified that regulate 
kidney development in both humans and 
rodents. Among these alterations, muta-
tions in RET, a receptor tyrosine kinase 
(RTK), were recently found in about 35% 
of patients with various forms of renal 
agenesis.2 In an effort to better understand 
how RET might lead to CAKUT, several 
laboratories have characterized Ret mutant 
animal models and deciphered the vari-
ous processes during mammalian kidney 
development that depend on Ret, and in 
doing so have provided valuable insights 
into kidney organogenesis and CAKUT 
pathogenesis. Today I will provide a brief 
overview of the diverse roles of Ret path-
way in early kidney development with par-
ticular emphasis on insights gleaned about 
the basis for signaling specificity from ani-
mal models.
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Gross Anatomy of RET
RET consists of three main domains, 
extracellular, transmembrane and cyto-
plasmic.14 The extracellular domain 
plays a role in receptor dimerization and 
interaction with one of its coreceptors 
and ligand (Fig. 1). While the predicted 
molecular mass of RET is 150 kDa, gly-
cosylation in the amino-terminus results 
in an approximately 170 kDa mature pro-
tein. The tyrosine kinase domain resides 
in the cytoplasmic portion. There are two 
major isoforms of RET, RET9 (1072aa) 
and RET51 (1114aa). These are generated 
by alternative splicing in the 3-prime (3') 
region of RET such that the carboxy ter-
minus of the mature protein is identical 
until residue 1063. Thus RET9 has nine 
amino acids in the carboxy terminus that 
are different than the 51 terminal residues 
in RET51.
GDNF-GFRα1-RET Signaling
Glial cell line-derived neurotrophic factor 
(GDNF) family ligands (GFLs) are a fam-
ily of four neurotrophic factors, GDNF, 
Neurturin, Artemin and Persephin 
(Fig. 1B). Interaction of a homodimer of 
one of the GFLs with a homodimer of one 
of their preferred coreceptors (GFRα1-4), 
increases affinity of GDNF-GFRα1 to 
interact with a RET homodimer.15 This 
results in a multicomponent activated 
receptor complex leading to phosphory-
lation of key tyrosine (Y) residues in the 
cytoplasmic domain. RET-Y905 is a site 
necessary for kinase activity and modu-
lates autophosphorylation of four key 
docking tyrosines that serve as binding 
sites for intracellular adaptors leading to 
activation of major signaling pathways. 
Activation of these pathways determines 
the type of biological response to be 
elicited in a cell. RET-Y905 regulates 
binding to Grb7/10, RET-Y981 binds to 
SRC, RET-Y1015 to PLCγ, and RET-
Y1096 which is only present in RET51, 
to GRB2. Further, RET-Y1062 serves as 
a multidocking adaptor site for several 
intracellular adaptors including SHC, 
FRS2, IRS1/2, DOK1, DOK4-6 and 
ENIGMA (Fig. 1C). Phosphorylation 
at RET-Y1062 enables binding to adap-
tors like SHC to activate PI3K/AKT or 
failure in children. Less severe abnormali-
ties such as mild hypoplasia (suggesting 
reduced branching morphogenesis and 
nephrogenesis) may remain undetected by 
conventional screening procedures, and 
may result in hypertension and chronic 
renal failure.
Diseases Associated with RET
RET is an acronym for “rearranged during 
transfection.” It was discovered as a gene-
rearrangement that resulted in transforma-
tion of NIH3T3 fibroblasts when human 
lymphoma DNA was transfected into these 
cells.7 RET encodes a single pass, trans-
membrane receptor tyrosine kinase (RTK) 
that resides at chromosome 10q11.2 in the 
human genome.8 It consists of 20 exons 
with a potential to generate two major iso-
forms due to alternative splicing in the car-
boxy terminus (Fig. 1) (see below).9 RET 
homologues exist in all vertebrates and 
have also been identified in Drosophila mel-
anogaster. RET mutations have been identi-
fied in several human diseases. Activating 
RET mutations predispose to hereditary 
oncogenic syndromes such as multiple 
endocrine neoplasia type 2 (MEN2), are 
present in 30–70% of sporadic medullary 
thyroid carcinomas, and have been identi-
fied in papillary thyroid carcinomas. More 
recently RET and estrogen receptor path-
way interaction was shown to be impor-
tant in development of breast cancer.10 
Inactivating RET mutations are a predom-
inant feature of hereditary Hirschsprung 
disease (HSCR, intestinal aganglionosis) 
and also found in a large number of spo-
radic HSCR.11 Majority of gain and loss 
of RET phenotypes known to date present 
in an autosomal dominant manner. RET 
mutations have been reported in patients 
presenting with MEN2 and HSCR, 
CAKUT and MEN2, and more recently 
in patients with isolated CAKUT, or with 
HSCR and CAKUT.2,12,13 These observa-
tions illustrate the potential for aberrations 
in RET signaling to predispose for both 
isolated as well as multisystem defects in 
urinary and other systems. They have led to 
increased efforts to understand the mecha-
nisms of RET function at cellular as well as 
at organ level in hopes of delineating how 
abnormalities of RET signaling can be 
associated with multiple syndromes.
Urinary System Development
There are three pairs of embryonic kid-
neys that develop in mammals in an ante-
rior to posterior direction: the pronephros, 
mesonephros and metanephros.3 First, the 
pronephros develops from a collection of 
cells in the intermediate mesoderm (IM) 
that undergo mesenchymal to epithelial 
transition and initiate the development 
of nephric duct (Wolffian duct, WD) 
(in mice at about E8.5d; in humans at 3 
weeks of gestational age). The proneph-
ros is a transient, nonfunctional struc-
ture that is followed by another transient 
structure, the mesonephros (at about E9d 
in mice; about 25d gestation in humans). 
The mesonephros contains a linear orga-
nization of nephrons along the growing 
WD. In mice only the rostral/anterior 
mesonephric tubules are connected to 
the WD. These later become part of the 
epididymis in males. The WD becomes 
the vas deferens.
Development of the definitive kid-
ney or metanephros in mice begins at 
E10.5-E11.5 as an outgrowth from the 
WD known as ureteric bud (UB, future 
collecting system).4,5 Specific signals from 
the metanephric mesenchyme (MM) reg-
ulate UB outgrowth into MM, a process 
called induction. Upon reaching the MM, 
the UB tip undergoes branching morpho-
genesis to form the collecting system. The 
initial UB stalk becomes the ureter. The 
branching UB tips reciprocally induce the 
surrounding mesenchyme (causing mes-
enchymal condensation), a process that 
stimulates nephrogenesis. At the same 
time, equally important events occur in 
the distal WD and the ureter that deter-
mine proper connection of the ureter to 
the bladder. The ureter undergoes remod-
eling which involves separation from 
the WD (future genital duct in males), 
insertion and migration into the trigone 
accompanied by common nephric duct 
(CND) degeneration.6 Abnormal ureteral 
maturation results in megaureter, hydro-
nephrosis, vesico-ureteral reflux, uretero-
pelvic junction (UPJ) abnormalities and 
obstruction, while abnormal UB induc-
tion results in renal agenesis, hypoplasia 
or dysplasia. More severe abnormalities 
in these processes will present in utero or 
early childhood and many result in renal 
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and in the embryonic kidney (metaneph-
ros).16 One active area of investigations 
is deciphering the biological need for the 
various RET isoforms and the signal-
ing cascades in kidney development and 
disease. Do they provide redundancy or 
specificity?
MAPK and PKC, respectively. These 
pathways regulate cellular processes such 
as proliferation, migration, survival and 
regeneration in a number of tissue spe-
cific stem cells/progenitors including the 
spermatogonial stem cells, enteric neural 
crest precursors, CNS and PNS neurons, 
MAPK cascades through recruitment of 
GRB2/GAB or GRB2/SOS, respectively. 
The PI3K/AKT pathway can also be 
activated by direct recruitment of GRB2-
GAB complex on phospho-RET-Y1096 
present in RET51. The major pathways 
activated by SRC and PLCγ are RAS-
Figure 1. ret gene structure and signaling. (A) Gene structure of RET. RET is located at chr 10q11.2 and consists of 20 exons (rectangular boxes). 
Depicted are two major ret isoforms, ret51 and ret9, generated by alternative splicing. (B) Diagram showing ret activation by glial cell line-derived 
neurotrophic factor (GDNF) family ligands (GFLs). A dimer of one of the four GFLs (GDNF; Neurturin, NrtN; Artemin, ArtN; Persephin, PSPN)  
associates with homodimers of one of the four GPi-linked corereceptor’s (GFrα1-4) to form multimeric complex with a ret homodimer. this leads 
to activation of ret kinase domain in the cytoplasmic side by phosphorylation, and downstream signaling cascades that regulate the indicated bio-
logical responses. (c) Gross anatomy of ret. Different ret domains are shown, extracellular, transmembrane (tm) and cytoplasmic domain that 
harbors the kinase activity regions. Key ret tyrosine (Y) residues, the preferred intracellular adaptors that they bind to, and the downstream signaling 
cascades that are activated are shown. Y905 is a residue important for ret kinase activity. Note the extra tyr Y1096 in the ret51 isoform directly 
binds to GrB2 to preferentially activate PI3K/AKt pathway. thus, both ret-Y1062 and ret-Y1096 can activate PI3K through GrB2-GAB1/2.
180 Organogenesis Volume 5 Issue 4
in older mice (unpublished observations). 
Interestingly, Gfrα1 expression in the kid-
ney is broader than Ret as it is also detected 
in the cap mesenchyme surrounding the 
branching UB tips and in a subset of cor-
tico-medullary proximal tubules in adult 
kidneys (unpublished observations).20,22,23 
Gfrα1 expression in structures that do 
not express Ret has been attributed to 
Ret-independent roles or in trans-Ret acti-
vation.24 Although, trans expression is dis-
pensable for normal kidney development, 
it may have unrecognized roles in adult 
kidney under pathological conditions.23
Biological Roles of  
Gdnf-Gfrα1-Ret in Kidney  
Development
Consistent with these expression patterns 
of Gdnf, Gfrα1 and Ret in the develop-
ing kidney, gene knock-out studies reveal 
that this pathway is essential for early kid-
ney development as the absence of Gdnf, 
Gfrα1 or Ret during embryogenesis in 
morphogenesis, Gdnf expression becomes 
more localized to the undifferentiated 
mesenchyme in the periphery and it is 
markedly reduced or undetectable in the 
mature kidney.4 The postnatal expression 
of GFLs is poorly defined in the kidney. 
Among the other GFLs, Neurturin is also 
expressed in the UBs of embryonic kid-
ney after E14. However, its physiological 
relevance is not known as Neurturin null 
animals have normal kidneys.17,21 In the 
initial stages of metanephric kidney devel-
opment both Ret and Gfrα1 are expressed 
in the ureteric bud stalk and the UB tip. 
During branching morphogenesis Ret and 
Gfrα1 expression diminishes in the UB 
stalk and their expression is more confined 
to proliferating UB tip cells. Towards the 
later stages of kidney development, high 
expression of both these genes is seen in 
the nephrogenic zone. Postnatal expression 
of Ret and Gfrα1 is less defined, although 
our recent observations using Gfrα1 and 
Ret reporter mice detect Ret and Gfrα1 in 
collecting ducts, with weaker expression 
Gdnf-Gfrα1-Ret Expression in the 
Kidney and Lower Urinary Tract
Much of our understanding of the role of 
Ret signaling pathway in kidney devel-
opment and function comes from the 
knowledge of spatio-temporal expression 
patterns of Ret signaling components in 
conjunction with phenotypic analysis of 
various Gdnf/Gfrα1/Ret mutant mice. 
Using in situ hybridization or analysis of 
reporter mice that express lacZ or green 
fluorescent protein (GFP) from Ret or 
Gfrα1 loci we have detected Ret and 
Gfrα1 expression in the developing WD 
in the pronephric kidney as early as E8.5d 
in mice (Fig. 2) (data not shown). Before 
UB budding at E10.5, increased Ret 
expression is detected in the distal WDs 
suggesting its role in UB induction.17-19 In 
mice, expression of Gdnf from the MM 
at about E10.5 activates Gfrα1-Ret signal-
ing in the WD to promote UB outgrowth 
into the MM and subsequent branch-
ing morphogenesis.20 During branching 
Figure 2. ret expression in early developing murine kidney. cartoon shows ret expression in relation to early stages of embryonic (e) murine kidney 
development. Wolffian duct (WD) is represented as vertical tube, ureteric bud (UB) as an outgrowth from caudal end of WD, common nephric duct 
(CND) at distal end of WD, and metanephric mesenchyme (MM) expressing Gdnf as red oval. Ret is first detected at E8.5 in cellular aggregates in the 
pronephros, then continues to be expressed in the growing WD during mesonephros development, albeit at lower levels. Intense ret expression is 
seen at the beginning of metanephric kidney at distal end where UB develops at E10.5. When UB reaches MM (at E11.5), first branching event occurs 
and intense Ret expression is observed in the tips of the UB. As branching continues, strong Ret expression is confined to UB tips, and Ret expression 
in WD becomes almost undetectable except in the cND, and becomes weaker in the uB stalk. the intensity of blue correlates with ret expression.
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acid receptor signaling positively regulate 
Ret in ureter maturation6,36 it was reported 
recently that members of the LAR family 
of protein tyrosine phosphatases negatively 
regulate Ret signaling in the formation of 
UVJ by controlling distal ureter apopto-
sis.38 Because UVJ abnormalities are a 
major cause of CAKUT, it is important 
to delineate specific pathways emanating 
from Ret or the CND niche that regulate 
ureter remodeling.
Insights into CAKUT from Animal 
Models with Altered Ret Signaling
While studies performed using Gdnf, 
Gfrα1, Ret null mice revealed an absolute 
requirement for Ret signaling in kidney 
development it wasn’t until Ret-mutants 
with severely diminished signaling were 
characterized that a wider role of Ret in 
kidney development was defined. One of 
these mutants expressed a Ret hypomor-
phic allele that in homozygous state causes 
intestinal aganglionosis and hypoplastic, 
cystic kidneys.39 Another example is a 
mouse that expresses a Ret dominant nega-
tive allele, that severely diminishes signal-
ing through Ret-Y1062 (Shc binding site 
urinary tracts (cloaca). It requires that dis-
tal portion of WD inserts normally in the 
cloaca (by E10.5), followed by CND degen-
eration (by E14.5), ureter separation from 
the WD and its migration into the trigone 
to connect to the bladder lumen.6,36,37 
Defects in this process can result in failure 
of the ureter to connect or traverse through 
the bladder and induce reflux nephropathy. 
In children this is one of the most com-
mon causes of renal failure. Degeneration 
of the CND is a critical event for proper 
connection of the upper and lower uri-
nary tracts and development of the male 
genital tract. Ret expression in the CND 
is markedly increased at E11.5 and both 
Ret and Gfrα1 are expressed in the CND 
until CND degenerates by E14.5. Gdnf is 
expressed in the surrounding urinary blad-
der wall. Consistent with this expression, 
a number of ureter abnormalities are pres-
ent in Ret-null mice and include unilat-
eral/bilateral ureter agenesis, blind ending 
ureters and failure to connect to the uro-
genital sinus.6,18 These studies suggest that 
Ret is likely involved in promoting CND 
apoptosis and ensuring proper connec-
tion of the upper and lower urinary tracts. 
While upstream pathways such as retinoic 
mice results in renal agenesis/rudimen-
tary kidneys and perinatal lethality.18,25-29 
Several findings suggest that Ret signaling 
also has a role in later kidney branching 
morphogenesis. These include expression 
of Ret signaling components in later kid-
ney development, inhibition of branch-
ing in vitro using Ret-activated pathway 
inhibitors and dependence of branching 
on stimulating or inhibiting Gdnf.30-32 
However, direct proof for Ret’s role post-
UB induction in vivo would require its 
conditional inactivation after early UB 
induction has occurred.
The agenesis phenotype in Gdnf/
Gfrα1/Ret null animals suggested a role in 
early UB induction and growth. A series of 
innovative studies to illuminate Ret’s role 
at a cellular level in orchestrating branch-
ing morphogenesis were undertaken by Dr. 
Costantini’s laboratory. Chimeric animals 
were generated in which “trackable” Ret-
null cells and wild-type cells contributed 
to the kidney. It was observed that dur-
ing branching these Ret-null cells never 
populated the UB tip, showing that intact 
Ret signaling is required for populating 
the UB tip.33 More recently, in a similar 
series of experiments it was shown that Ret 
activity was necessary to modulate WD 
epithelial cell rearrangements at the distal 
WD prior to UB budding.34
To determine if Gdnf in MM provides 
tropic cues to the UB to reach the MM 
and branch, Shakya et al. expressed Gdnf 
exclusively in the WD by expressing Gdnf 
under the regulation of HoxB7 promoter 
in the background of Gdnf null mice.35 
They observed that generalized expres-
sion of Gdnf only in WD and the urinary 
tree was able to support metanephric kid-
ney development. However, ectopic UBs 
also develop, indicating that expression of 
Gdnf in MM is not necessary for the UB 
to reach the MM and undergo branch-
ing morphogenesis. This suggests that 
there are redundant cues in MM for UB 
tropism.
Gdnf, Gfrα1, Ret Signaling in the 
Lower Urinary Tract
Formation of the ureterovesicular junction 
is a critical event in ensuring the proper 
union and communication between the 
upper (derived from WD) and lower 
Figure 3. Hypomorphic ret allele provides evidence that varied ret signaling is associated with 
different cAKut manifestations. (top row), compared with wild-type (wt) mice, RetDN/+ mice (ex-
press a ret form with severely reduced, but not absent, ret-Y1062 signaling) showed a spectrum 
of renal defects including bilateral small kidneys and unilateral renal agenesis (k, kidney; a, adrenal; 
ub, urinary bladder, t, testis; o, ovary; adrenal gland, arrowhead). (Bottom row) Bar graph shows 
decreased total number of glomeruli in RetDN/+ kidney at birth (n = 3 animals, 5 kidneys) compared 
with wild-type litter mates (n =3 animals, 6 kidneys) (*p < 0.001, mean ± s.e.m). H&e-stained sec-
tions show tubulocystic degeneration (arrows) in approximately 50% of 3- to 4-week-old RetDN/+ 
mice (6 of 12) (co, cortex; me, medulla; pe, pelvis). Scale bar = 5 mm in top row, and 600 μm in 
bottom row. The figure is adapted from Jain et al.40 with permission.
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CND degeneration. This new phenotype 
associated with abrogation of only one spe-
cific signaling cascade defines yet another 
role of Ret in CAKUT that could not have 
been realized by knockout studies.
To further explore whether redun-
dant signaling from Grb2 masks essential 
roles of the Src or the Shc adaptor site, 
mice with mutations in Plcγ, Src and Shc 
binding sites were made in context of the 
RET9 isoform.42 The results in general 
show that the Grb2 containing carboxy 
terminus provides redundancy to both 
the Src (RET9-Y981F) and multidocking 
Shc (RET9-Y1062F) sites, although the 
impact at these sites appear to be different. 
For instance, the RET9-Y981F mutants 
show incomplete penetrance of CAKUT 
with only a subset harbor megaureters. 
On the other hand loss of Shc binding in 
the face of absent Grb2 resulted in phe-
notype quite similar to Ret-null mice, 
bilateral agenesis or kidney rudiments 
(Fig. 4). The same result was also seen 
in mice expressing a chimeric Ret9-
Y1062F allele made by fusion of mouse 
Ret extracellular and human Ret intra-
cellular domains.43 A different approach 
to examine the role of the Shc binding 
site was taken by creating this mutation in 
the endogenous mouse Ret (i.e., it would 
express this mutation in both Ret9 and 
Ret51). This resulted in slightly hypoplas-
tic kidneys.44 Together these studies sug-
gest that Grb2-mediated signals provide 
redundancy to Src and Shc binding sites 
and totally abrogating Grb2 (through Shc 
or direct Grb2 binding) is the reason for 
agenesis in Ret-null mice. Interestingly, 
the role of Grb2 on the Src site in kidney 
development seems to be different than 
on the Shc site as Ret-Src mutants show a 
megaureter phenotype as opposed to agen-
esis typically seen in all Ret9 mutants defi-
cient in Shc binding. These animal models 
provide remarkable insights into specific-
ity of Ret-activated signaling cascades that 
determine the manifestation of different 
types of CAKUT.40,42-44
Genetic Interactions of Ret  
Signaling Complexes that  
Influence Kidney Development
Both positive and negative regulators 
influence kidney development. These 
normal kidney or ENS development.39 This 
suggests that the carboxy-terminus of Ret51 
perhaps has an inhibitory role that could be 
either due to the different nine residues in 
the two isoforms or due to the additional 
Grb2 binding site. In contrast, when mice 
were made that exclusively express human 
wild-type RET9 or RET51 isoforms, it 
was found that either isoform is compe-
tent for proper kidney development.42 
Further, mice in which the nine residues 
after RET1063 in RET9 and RET51 were 
swapped also did not manifest differences 
in kidney development. This suggests that 
the extra or different residues in carboxy-
terminus between RET9 and RET51 are 
of no significance for normal development 
and that the portion of RET51 containing 
the Grb2 binding site is dispensable.42 The 
reasons for the different results between the 
two groups are not entirely clear. However, 
the findings raise the possibility that in 
different contexts the isoforms could have 
redundant or unique roles.
To examine the biological roles of each 
of Ret’s major tyrosine adaptor docking 
sites mice were made that transduce sig-
nals from all docking sites except one.42 
This was accomplished by the generation 
of mice that only express mutations (Tyr-
Phe) in Src, Plcγ or Shc adaptor sites or 
that lack the carboxy terminal 43 residues 
in RET51 with the Grb2 site. The results 
show that only the Plcγ mutants (RET51-
Y1015F) were not able to support proper 
kidney development (Fig. 4). In fact, abro-
gation of the Plcγ site resulted in a quite 
complex CAKUT phenotype with bilateral 
megaureters, hypoplastic and dysplastic 
multicystic kidneys, failure of separation 
of gonadal duct from the ureter leading 
to attachment of gonads to the urinary 
tree in both males and females, and pos-
sibly distal ureter abnormalities (Fig. 5). 
Characterization of these mutants during 
embryogenesis revealed that the phenotype 
is partly related to presence of supernumer-
ary ureters and partly due to branching 
defects. However, additional studies during 
mesonephric and early metanephric kidney 
development will likely provide insights 
into the developmental basis for these 
results including defining whether UB 
sprouts from the right position, and prob-
lems associated with mesonephros degen-
eration, insertion of WD into cloaca and 
and activate PI3K/MAPK pathway).40 
This mouse presents with varying degrees 
of abnormal kidneys including bilateral 
hypoplasia, unilateral hypoplasia and uni-
lateral agenesis (Fig. 3). Many of these mice 
survive for several weeks postnatally and 
a subset of the mice develops renal cysts. 
Eventually these mice fail to thrive and die 
due to varying degrees of small and large 
bowel aganglionosis. Results from these 
studies not only created useful animal dis-
ease models, but also provided a glimpse 
of wider roles of Ret pathways in kidney 
development especially insights into how 
varying activities of Ret are associated 
with a spectrum of renal malformations, 
Ret’s potential role in postnatal collecting 
duct cystic abnormalities, and how differ-
ential Ret activity can impact development 
of the urinary and other systems.
While my lecture focused on Ret and 
downstream signaling in kidney develop-
ment, it should be noted that several fac-
tors such as Eya1, Sal1, Pax2, Six2, Wnt11 
or Gdf11 can also modulate Ret signaling 
and influence kidney branching by alter-
ing Gdnf expression in the mesenchyme or 
by modulating the availability of Gdnf to 
Ret such as by 2-O sulfation.5,41 Animals 
with mutant forms of these genes present 
with a range of kidney defects due to aber-
rant Ret signaling.
The Role of Specific Ret-Activated 
Pathways in CAKUT Pathogenesis
Ret activates several major signaling cas-
cades and exists in at least two major iso-
forms. To ascertain whether each makes 
an incremental contribution towards UB 
induction, or whether each has a specific 
role, we and others have undertaken stud-
ies to examine the impact of individual Ret 
pathway mutants and isoforms on organo-
genesis. One of the questions examined 
was the biological relevance of the extra 
Grb2 docking site that preferentially acti-
vates PI3K/AKT pathway in the Ret51 
isoform. Two groups pursued this question 
by characterizing mice that express exclu-
sively either the Ret9 or Ret51 isoform. 
Interestingly, quite different results were 
obtained. A mouse expressing only Ret51 
where Ret51 was a chimeric form consist-
ing of mouse extracellular-human cytoplas-
mic domain was not able to fully support 
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Figure 4. For figure legend, see page 184.
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Figure 4. roles of ret isoforms and downstream cascades in kidney development. (A) Schematic of the different wild-type ret9, ret51 and their 
respective mutant knocked-in alleles. the different domains and sizes of the ret9 and ret51 alleles are indicated. the red and blue colors represent 
the area of divergence between the two ret isoforms. Also indicated are the key docking tyrosine (Y) residues. Homozygous mice were generated 
that harbor tyr→Phe (Y→F) for each of the indicated tyr except Y1096. ret51(cdel) is an allele where residues 1063–1072 of ret9 were replaced 
with residues 1063–1072 of ret51 (results in receptor that is essentially similar to ret51 with deletion of residues 1073–1114, including Y1096). 
ret9(51c) is an allele where residues 1063–1072 of ret51 were replaced with residues 1063–1072 of ret9 (results in a receptor that is essentially 
similar to ret9 with c-terminus of ret51 including Y1096). (B) Hematoxylin-eosin-stained kidney sections of homozygous mice for the indicated 
knocked-in alleles at P0. Left column shows all the mutants in the context of ret51 isoform, and the right column in ret 9 context. Note wild-type 
forms of ret9 and ret51 have redundant functions in kidney development. except for ret-PLcγ mutant ret51(Y1015F) individual abrogation of the 
key docking sites was dispensable. However, these same docking sites show dramatic kidney defects when the c-terminal Grb2 binding site is also 
deleted (mutations in ret9 context). Without Src and Grb2, there was a partially penetrant megaureter (see Fig. 7); without PLcγ (individually or 
without Grb2 site) kidneys are small and show cysts and dysplasia; without Shc and Grb2 (ret9-Y1062F), only kidney rudiments or agenesis is seen. 
thus direct Grb2 binding site provides some redundancy to Y981 and Y1062 docking sites in kidney development. In these studies, swapping the 10 
residues following 1063aa between the two isoforms did not appear to influence kidney development suggesting that differences in the isoforms are 
not due to these regions. Adapted and modified from Jain et al.42 with permission.
Figure 5. complex cAKut phenotype ret51(Y1015F) due to supernumerary ureters and decreased branching. (A) Histological and gross features 
of ret-Y1015F-PLcγ signaling mutant. the H&e-stained pictures at P0 show cystic hypodysplastic kidney (left), dilated ureters and possible distal 
stricture (middle) and failure of testes to separate from the urinary system (right). the gross photograph shows massive megaureter/hydroureter and 
barely any recognizable kidney parenchyma in 4 week old RET(Y1015F) mutant mice. (B) Whole mount Dolichos Biflorus Agglutinin-FITC (DBA-FITC) 
staining of e15.5 kidneys. top: Normal honeycomb pattern of ureteric bud branching, single ureters entering the bladder (white dot), and separation 
of Wolffian duct (wd) from the ureter was evident in kidneys (K) of mice expressing WT, RET51 and RET51(Y1062F). In RET51(Y1015F) animals, note 
bilateral small kidneys with supernumerary uBs (arrows) that enter the mesenchyme but show decreased branching and failed to separate from the wd 
(white dashed line). the testes (t) were also abnormally positioned. Bottom: Imaging of the above kidneys by confocal microscopy clearly depicts the 
dramatic deficit in branching morphogenesis (arrowheads indicate branch points) in homozygous RET51(Y1015F) kidneys. Scale bar: 100 μm. Adapted 
and modified from Jain et al.42 with permission.
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agenesis in transgenic mice expressing 
human SPRY2 in the UB could be rescued 
by Gdnf or Fgf7, supporting that Fgf sig-
naling has the potential for stimulating 
UB and branching.45 Recently, Maeshima 
et al. showed that Fgf7, induced UB out-
growth in Ret null WDs when activin 
signaling was inhibited.53 Conclusive evi-
dence for participation of other RTKs 
in the network of Ret-Spry1 in the early 
events of WD growth to sculpt the meta-
nephric kidney would require generation 
of multiple mutant alleles including Fgf 
pathway mutants, Spry1 and Ret signaling 
mutants.
An important observation from the 
Spry1:RET9-Y1062F mice is that the kid-
ney defects were normalized but the intes-
tinal aganglionosis was not (Fig. 6). So 
in essence these double mutants manifest 
as HSCR only even though they harbor 
detrimental mutations in RET known to 
severely affect kidney development when 
present in isolation. Thus, depending on 
the combination of the RET and SPRY1 
mutations inherited/expressed, one could 
be predisposed to CAKUT alone (SPRY1 
deficiency), renal agenesis and HSCR 
(RET9-Y1062F mutant), or HSCR alone 
(double Spry1;Ret homozygous mutant 
mice). These organ specific genetic inter-
actions may explain some cases of HSCR 
where RET mutations in the cytoplasmic 
domain may not have any overt renal 
anomalies or the basis for coexistence of 
CAKUT and HSCR. It would be impor-
tant to delineate other putative modifiers 
of Ret mutant phenotypes to get a bet-
ter understanding of organ specificity in 
disease manifestation. Further, because of 
possible genetic interactions, patients with 
any of the diseases related to RET, such 
as HSCR, MEN2 or CAKUT, present-
ing alone or in combination, may benefit 
by screening for mutations in RET and 
other genes that modify RET’s biological 
responses.
Genetics of CAKUT
Recent advances in genetics and analysis of 
a number of gene-deficient mouse models 
that lead to renal malformation have led 
investigators to examine the implications 
of their findings in humans with CAKUT. 
These studies point to strong associations 
primarily dependent on signals emanat-
ing from Ret-Y1062, a residue important 
for UB induction. We tested whether the 
Spry1 CAKUT phenotype will normal-
ize in the background of RET9-Y1062F 
mutants.51 We observed that double 
homozygous Spry1:RET9-Y1062F mutant 
mice have essentially normal kidneys pro-
viding in vivo evidence that Ret and Spry1 
genetically interact (Fig. 6).
This result has several important impli-
cations. First, the ability to normalize two 
remarkably different defects, renal agen-
esis in RET9-Y1062F and the complex 
CAKUT phenotype in Spry1 null, by 
expressing them in the same genetic back-
ground may be applicable in correcting 
these disparate defects in fetuses by modu-
lating these individual signaling pathways. 
Second, it provides evidence for the impor-
tance of negative regulators in control-
ling RTK-mediated kidney development. 
Third, it provides support to the possibil-
ity that RTKs other than Ret that may 
play a role in kidney development but are 
normally repressed by Spry1 (see below). 
Studies from Basson et al. and Rozen et al. 
provide a model where without Spry1, there 
is RTK overdrive that leads to extra UB 
outgrowths especially in the mesonephric 
duct. This is mainly dependent on signals 
from Ret-Y1062 which in the presence of 
wild-type levels of Spry1 are somewhat 
dampened in the anterior WD and there-
fore do not produce supernumerary ure-
ters. Without Spry1, Ret-Y1062 dependent 
activation of MAPK is at a much higher 
level producing ectopic ureters since abro-
gation of Ret-Y1062 signaling in Spry1 
null does not produce ectopic ureters. The 
fact that UB normally grows from distal 
WD in double Ret9-Y1062F: Spry1 null 
animals suggests that other RTKs or other 
Ret-dependent signaling pathways must 
be compensating in these double mutants 
to produce normal kidneys since the main 
inducer of UB, Ret-Y1062 signaling, has 
been abrogated (Fig. 6). One of these 
pathways appears to be Fgf signaling. The 
role of signaling by Fgf receptors as an 
alternate pathway for early UB outgrowth 
was suggested by studies where aberrant 
expression of soluble Fgfr2IIIb resulted in 
renal agenesis.52 Chi et al. demonstrated 
interactions between Gdnf, Fgf7, Wnt11 
and Spry signaling by showing that renal 
include activating factors upstream, either 
in the MM or in mesonephric mesoderm 
influencing Ret activity through Gdnf or 
in the UB, and downstream of Ret such 
as Wnt11 (forms a positive feedback loop), 
and repressors such as Spry in the WD 
or metanephros.45 I will briefly review 
examples where direct evidence of genetic 
interactions between Ret signaling com-
plex and other genes has been observed 
in vivo. One of the first examples of this 
came from studies of Spry1 null and Gdnf 
heterozygous animals. Without Spry1, 
mice develop a CAKUT phenotype with 
features of bilateral megaureters, gonadal 
abnormalities and multiplexed hypoplas-
tic/dysplastic kidneys.46 Because these mice 
have supernumerary ureters and Gdnf in 
kidney organ cultures can induce extra-
neous UB budding and ectopic ureters, it 
was suggested that perhaps Gdnf was aber-
rantly expressed leading to the observed 
phenotype. Further support for this con-
cept comes from several mouse mutants 
that have supernumerary ureters due to 
failure to limit Gdnf expression to poste-
rior IM.47,48 However, Basson et al. did not 
detect abnormal anterior Gdnf expression 
in the IM in Spry1 null mice suggesting 
that WD in the Spry1 null mice is more 
responsive to Gdnf. They supported this 
idea by breeding Spry1 homozygous mice 
onto Gdnf heterozygous background 
and found that in a majority of double 
homozygous/heterozygous, the CAKUT 
phenotype appears to normalize, mean-
ing Gdnf haploinsufficiency almost cures 
CAKUT in Spry1 null mice.46 Basson et 
al. also demonstrated that Spry1 signal-
ing was important in kidney branching, 
and this was dependent on Spry1 interac-
tions with Gdnf-Ret signaling.49 However, 
they showed that the mechanism of Spry1 
interaction with the Ret pathway during 
branching was different than its role in the 
WD. In UB branching Gdnf expression 
was much wider in MM in Spry1 nulls, 
whereas in WD no increased or wider 
Gdnf expression in the anterior IM was 
noted. The increased Gdnf in MM was 
likely due to increased Wnt11 expression in 
UB as it induces Gdnf expression in MM. 
Reducing Gdnf dosage also normalized the 
branching defects in Spry1 null animals.
Spry proteins inhibit the MAPK 
cascade.50 MAPK activation by Ret is 
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of 33 patients with unilateral or bilateral 
agenesis.2 Several of these were in cyto-
plasmic domain of RET suggesting that 
decreased RET activity in humans results 
in renal agenesis, as in the numerous Ret-
mutant animals discussed above. Since ani-
mal studies now suggest a much larger role 
of RET in CAKUT, further investigations 
in larger human cohorts and in a broader 
urinary system development and have been 
found to be associated with mutations in 
patients with isolated kidney defects or in 
syndromes include BMP4, FOXC1, ACE, 
Chr13q33-34, GATA3, PAX2, EYA1, 
SAL1 and SIX1.55-58 Animal studies have 
indicated that many of these influence 
Gdnf-Ret signaling. Recently, RET cod-
ing region mutations were identified in 12 
between genes deemed important from ani-
mal studies and the identification of muta-
tions in these in CAKUT. For example, 
Robo2 disruption results in megaureters 
with distal obstruction and dysplastic kid-
neys.47 Sequencing of ROBO2 in CAKUT 
samples identified a subset of VUR patients 
with mutations that disrupt ROBO2 
function.54 Other genes that have roles in 
Figure 6. Genetic interactions between Ret and Sprouty1 (Spry1) are specific to kidney. (A) Loss of Sprouty1 rescues renal defects found in animals 
expressing ret9 Y1062F. Whole mount of genito-urinary tracts from newborn mice of the indicated genotypes. Note that compared to individual 
ret9-Y1062F or Spry1-/-, the double ret9-Y1062F:Spry1-null mice have essentially normal appearing kidneys and ureters. thus, both the agenesis and 
complex cAKut phenotypes are rescued when these mutations are in the same background. (B) Lack of effect of Spry1 deficiency on the enteric in-
nervation defects observed in RetRET9(Y1062F/Y1062F) mice, as revealed by whole mount acetylcholine esterase activity of digestive tracts from newborn mice. 
thus, in the enteric nervous system Spry1 does not interact with ret as it is not able to rescue Hirschsprung disease phenotype in ret-Y1062F mu-
tants. Adapted and modified from Rozen et al.51 with permission. (c–F) model summarizing ret-Spry1 interactions in the kidney. In normal situations, 
ret-activated cascades and Spry1 inhibition on ret and other rtKs is in correct balance leading to normal kidneys (c). In absence of ret-Y1062 signals, 
the main residue that determines uB outgrowth, kidneys don’t develop; other rtKs cannot compensate as Spry1 is still inhibiting them (D). Without 
Spry1, ret-mAPK inhibition is gone leading to perhaps enhanced ret-Y1062-mAPK signaling, as is also from other rtKs that may have the potential to 
influence UB growth, thus leading to multiple ectopic UBs from the WD (E). In the absence of both Spry1 and Ret-Y1062, normal kidneys are observed 
because, other rtKs or other ret-tyr can potentially activate uB growth mechanisms in distal WD as repression from Spry1 is absent; ectopic uBs 
are not seen since retY-1062 is the major signaling mechanism for uB growth in anterior WD.
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in distal ureter maturation have been dis-
covered, and insights derived that explain 
how complex phenotypes that encompass 
distal ureter abnormalities such as mega-
ureter/hydroureter and defects such as 
renal hypoplasia or dysplasia can develop 
either together as seen in Ret-Y1015F-Plcγ 
mutant mice or in isolation as seen in Ret 
hypomorphic mice. Experiments with 
genes modifying Ret phenotypes have 
also provided information that depending 
on the context, upper and lower urinary 
tract abnormalities can be detected sin-
gly, or together. The relevance of findings 
from animal Ret mutant models was con-
firmed by the discovery of high incidence 
of RET mutations in patients with kidney 
agenesis.
While significant strides have been 
made in our understanding of Ret biology 
years ago, efforts of several laboratories 
have markedly enhanced our understand-
ing of the roles of Ret signaling complex 
in urinary system development. These 
efforts have defined new roles of Ret in 
kidney development through analyses of 
hypomorphic or defined Ret-signaling 
mutants and helped characterize how vari-
ations in amounts or type of Ret signal-
ing can result in a wide array of CAKUT 
phenotypes. Besides delineating specific-
ity of Ret-dependent cascades and other 
positive and negative regulators of Ret 
in kidney development, the efforts have 
led to a better understanding of the basic 
processes of branching morphogenesis, 
reciprocal interactions, cell proliferation, 
migration, differentiation and survival, 
and above all, of kidney and lower uri-
nary tract development. New roles of Ret 
spectrum of CAKUT would be needed to 
determine the incidence of RET mutations 
in these malformations, and more impor-
tantly where or what function of RET is 
affected in these mutations. Since RET has 
pleiotropic roles in human diseases includ-
ing HSCR, MEN2 syndromes, patients 
presenting with RET mutations in these 
conditions should be closely monitored for 
renal defects. CAKUT patients should be 
monitored for HSCR phenotype as RET 
intergenic interactions with its positive 
and negative regulators can influence orga-
notypic specificity of disease manifestation 
(Fig. 7).
Conclusion
Since the initial discovery that Ret is 
essential in kidney genesis almost fifteen 
Figure 7. many faces of ret dysfunction in kidney. Schematic shows the major key ret docking tyrosine and the preferred activated pathways. Also, 
depicted are the roles of these in the major processes of kidney development and examples of the phenotypes that are seen due to defects in these 
processes. The spectrum of phenotypes in Ret mutants are shown. Note that influence of other modifier genes such as Spry1 or Gdnf can give com-
bination of intermediate phenotypes that are not represented here. thus, alterations in ret signaling pathways by changes in overall expression, or 
individual cascades. or through other genes encompasses majority if not all of CAKUT phenotypes. Parts of this figure are adapted from Jain et al.40,42 
with permission.
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signaling pathways. It has always been 
in an interesting biological question why 
that occurs. From experiments in vitro 
it seems to be that they activate MAPK 
in a similar fashion as the intracellular 
adaptors that activate Ras-Raf-Erk1/2 
are similar. The basis for specificity for 
different RTKs in part comes from their 
specific ligands or coreceptors or cell-type 
specific expression patterns.60 Similarly, 
Spry proteins are themselves regulated at 
transcriptional and translational level by 
RTKs, and in turn they can inhibit Ras-
MAPK pathways activated by RTK. This 
can also vary at cell-type leveI. Thus there 
is potential for intra RTK as well as inter 
RTK modulation of MAPK cascades.
Feng Chen PhD, Assistant Professor of 
Medicine, Washington University School 
of Medicine: It has been proposed in a 
recent paper34 that migration of Wolffian 
duct epithelial cells near the caudal part 
of the Wolffian duct is involved in the 
formation of the ureteric bud. That pro-
cess depends on Ret activity. You describe 
in some of your mutants the formation of 
multiple budding sites and some are very 
anterior to the normal site. Do you see 
any abnormal cell movement associated 
with the formation of the ectopic buds 
and what do you think is the positional 
determinant for these buds?
Sanjay Jain: We haven’t really looked at 
migration in our Ret mutants in the kid-
ney in detail. We do see an increased Ret 
signal at the distal Wolffian duct before 
the UB evaginates, which we believe is 
due to increased proliferation. Studies 
from the  laboratory Dr. Constantini, 
Columbia University, show this may be 
due to migration of anterior WD cells in 
this zone and epithelial rearrangements.34 
We have not explored this phenomenon 
in the ectopic UBs seen in our mutants. 
Regarding the question of the extra bud-
ding from the mesonephric portion of the 
Wolffian duct, we believe in these regions 
Spry1 inhibition is likely overcome due to 
increased Ret expression/signaling, thus 
tipping the balance in favor of Ret acti-
vated MAPK pathways. This was shown 
by Basson et al. who observed increased 
MAPK activity in WD with ectopic 
UBs,46 and in their studies in which 
Spry1 deletion in UB causes accelerated 
UB branching.49
interacting genes. Further, whole genome-
wide studies are needed to discover mul-
tigenic causes of CAKUT that may not 
be apparent from screening of individual 
target genes.
Questions and Answers
Andrew Siedlecki MD, Instructor in 
Medicine, Washington University School 
of Medicine: When you breed the SPRY1 
knock out with your RET knockout, 
that results in an interesting rescue. Do 
you have any idea whether or not there 
is a proliferative pathway that SPRY1 
is using as an alternative to the MAPK 
kinase pathway, for instance the mTOR 
pathway?
Sanjay Jain MD, PhD, Assistant 
Professor of Medicine and Pathology, 
Washington University School of 
Medicine: I don’t know of studies where 
Spry1 modulates mTOR pathway. What is 
known from literature about SPRY1 is that 
MAPK pathway inhibition is its major tar-
get.59 Initially, Spry members were shown 
to inhibit Fgf signaling in lung, and more 
recently evidence has been provided for 
Spry inhibiting Ret and Fgf pathways in 
the kidney.45-49 That is why we think that 
Fgf signaling may play a role. Chi et al.45 
also alluded to role of Spry proteins in 
modulating pathways other than MAPK 
in kidney, however, the molecular nature 
of these have not been defined. Dr. Sanjay 
Nigam from UCSD has also shown that if 
you treat WD derived from Ret knockout 
animals with FGF7 in presence of inhibi-
tors of activin you can actually induce UB 
outgrowth further supporting Fgf as an 
alternate pathway.53
Jianghui Hou PhD, Assistant Professor 
of Medicine, Washington University 
School of Medicine: What is the bio-
chemical basis for the RET signaling? It 
seems that RET activates PI3 kinase and 
MAPK kinase, but another kinase path-
way upstream (SPRY1-raf) also activates 
MAPK. What do you think is the phos-
phorylation site for MAPK kinase down-
stream of RET? Could it be different 
from the other one and is that why there 
are two different phenotypes?
Sanjay Jain: The question is about 
this idea of convergence of many dif-
ferent cascades into these common 
and kidney development, several aspects 
remain to be explored. For example, devel-
opmental processes that lead to the com-
plex phenotypes in Ret mutants remain to 
be defined particularly the events during 
mesonephric kidney development. Also, 
it must be determined what specific sig-
nals regulate ureter maturation. Since 
many mutants in positive and negative 
regulators produce the same phenotypes 
as Ret mutants, studies that examine 
which of these interact with Ret in vivo 
need to be conducted in order to deter-
mine which pathways in kidney develop-
ment converge and which interactions are 
relevant in kidney versus in other organs 
that are dependent on Ret for develop-
ment. Specific questions that should be 
addressed include the following: Is there 
specificity of Spry proteins in kidney ver-
sus gut development? Do other genes such 
as Slit2, Bmp4, Foxc1 interact with any 
of the specific Ret cascades? What are the 
relevant molecules downstream of Ret 
that modulate kidney development? Are 
there any positive or negative feedback 
mechanisms that are important?
Ret continues to be expressed in devel-
oping kidney post-UB induction. Its 
expression pattern changes from being 
ubiquitous in the urinary tree to more 
focal. Deciphering the transcriptome of 
this Ret-positive population in temporal 
manner in order to delineate the global 
changes that occur in these progenitors as 
kidney development proceeds could iden-
tify new molecules that may have impor-
tant roles in kidney development. Further, 
studies need to address if developmentally 
important genes such as Ret have roles in 
regeneration of adult kidney after injury as 
increasingly it is being found that molecu-
lar signals that are important during early 
development may have roles in regenerat-
ing damaged kidneys after injury.
Defining molecular aberrations lead-
ing to CAKUT in Ret mutant animals 
and in humans will uncover biomarkers 
that can be used for the early diagnosis 
of renal abnormalities in children. While 
finding RET mutations in patients with 
renal agenesis is certainly a big step in this 
direction, larger scale studies encompass-
ing a wide spectrum of CAKUT pheno-
types, in different populations can define 
clinically relevant mutations in RET and 
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